Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies

Abstract

Get full access to this article

View all access options for this article.

References

Gussin

Ignat

Varga

Deodorescu

. Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 2001; 44: 376–383.

Mahler

Silverman

Shulte-Pelkum

Frizler

. Anti-Scl-70 (topo-I) antibodies in SLE: myth or reality? Autoimmun Rev 2010; 9: 756–760.

Hamidou

Audrain

Masseau

Aqard

Moreau

. Antitopoisomerase-I in systemic lupus erythematosus as a marker of severe nephritis. Clin Rheumatol 2006; 25: 542–543.

Simon

Czömpöly

Berki

et al.

Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus. Int Immunol 2009; 21: 415–422.

Bentow

Swart

et al.

Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens. Clin Chim Acta 2013; 424: 141–147.

Fredi

Cavazzana

Quinzanini

et al.

Rare autoantibodies to cellular antigens in systemic lupus erythematosus. Lupus 2014; 23: 672–677.